Transgene (France) Investor Sentiment

TNG Stock  EUR 0.73  0.04  5.19%   
About 61% of Transgene's investor base is looking to short. The analysis of current outlook of investing in Transgene SA suggests that many traders are alarmed regarding Transgene's prospects. The current market sentiment, together with Transgene's historical and current headlines, can help investors time the market. In addition, many technical investors use Transgene SA stock news signals to limit their universe of possible portfolio assets.
  
over two months ago at news.google.com         
Taysha Gene Therapies Unjustified Sell-Off - Enough Cash Runway And Promising Rett Syndrome Data - S...
Google News at Macroaxis
over two months ago at news.google.com         
Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024 - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Transgene SA Earnings Call Transcript Highlights Promising Clinical Data ... - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Transgene to Report Major Clinical Data before the end of 2024 Confirmed Financial Visibility until ...
Google News at Macroaxis
over three months ago at news.google.com         
Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation - Yahoo Fi...
Google News at Macroaxis
over three months ago at news.google.com         
Transgene to Participate in HTID Conference and Investor Access Forum in Paris - Yahoo Finance UK
Google News at Macroaxis
over three months ago at news.google.com         
Transgene Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC - Yahoo Fina...
Google News at Macroaxis
over three months ago at news.google.com         
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2024 - Yahoo Financ...
Google News at Macroaxis
over six months ago at news.google.com         
Is Transgene Using Too Much Debt - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
If You Had Bought Transgene Stock Five Years Ago, Youd Be Sitting On A 73 percent Loss, Today - Yaho...
Google News at Macroaxis
over six months ago at news.google.com         
Availability of Transgenes 2023 Universal Registration Document - Yahoo Canada Finance
Google News at Macroaxis
over six months ago at news.google.com         
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head Neck...
Google News at Macroaxis
over six months ago at news.google.com         
Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human...
Google News at Macroaxis
over six months ago at news.google.com         
Neurogene Stock Gene Therapy Specialist May Break Chain Of Failed Mergers - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Taysha Gene Therapies, Inc. Q4 2023 Earnings Call Transcript - Seeking Alpha
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Transgene that are available to investors today. That information is available publicly through Transgene media outlets and privately through word of mouth or via Transgene internal channels. However, regardless of the origin, that massive amount of Transgene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Transgene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Transgene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Transgene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Transgene alpha.

Transgene Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Transgene Stock analysis

When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges